Oncothyreon Announces Second Quarter 2014 Financial Results Conference Call
August 04 2014 - 8:00AM
PR Newswire (US)
SEATTLE,
Aug. 4, 2014 /PRNewswire/ -
Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will
conduct a conference call on Monday, August
11, 2014 at 4:30 p.m. Eastern
Time (1:30 p.m. Pacific) to
discuss its second quarter 2014 financial results and provide a
corporate update and review of its pipeline of products in
development.
To participate in the call by telephone, please
dial (877) 280-7291 (United
States) or (707) 287-9361 (International). In
addition, the call will be webcast live and can be accessed on the
"Events" page of the "News & Events" section of Oncothyreon's
website at www.oncothyreon.com. An archive of the webcast
will be available after completion of the discussion and will be
posted on the Oncothyreon website.
About Oncothyreon
Oncothyreon is a biotechnology company
specializing in the development of innovative therapeutic products
for the treatment of cancer. Oncothyreon's goal is to develop and
commercialize novel synthetic vaccines and targeted small molecules
that have the potential to improve the lives and outcomes of cancer
patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Copyright 2014 PR Newswire
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart
From Sep 2023 to Sep 2024